Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)



Status:Active, not recruiting
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:September 2013
End Date:February 2019

Use our guide to learn which trials are right for you!

The two objectives of the study are to assess the current standard of care treatment outcome
in none/mild, moderate and severe calcified coronary lesions and to obtain financial data
and procedure data to support reimbursement initiatives and health care economics analysis.

This prospective, non-randomized, multi-center study includes subjects who meet all of the
inclusion and none of the exclusion criteria and sign the ICF. This study may treat up to
approximately 500 subjects at up to 50 active sites in the U.S. Subjects will be followed up
to three (3) years. Subjects will be stratified into one (1) of three (3) arms based on the
degree of calcification in the coronary lesion as defined by this protocol. An interim
analysis of standard of care treatment used will be performed after an arm has 40 subjects
whom have completed the discharge visit. The duration of the study is expected to be
approximately four (4) years.

Inclusion Criteria:

1. Subjects must be at least 18 years of age.

2. Subjects must be scheduled for percutaneous coronary revascularization involving
stent deployment in de novo coronary lesions. Percutaneous coronary revascularization
is defined as treatment with commercially available devices that may include but not
limited to balloon angioplasty, cutting balloon, rotablation, etc. followed by the
stent placement.

3. Subjects CK-MB must be less than or equal to the upper limit of lab normal value
within eight (8) hours prior to procedure. If CK-MB results are not yet available
prior to initiating procedure, subjects Troponin I or Troponin T must be less than or
equal to the upper limit of lab normal value within eight (8) hours prior to the
procedure.

4. The target lesion must be a de novo coronary lesion that has not been previously
treated with any interventional procedure.

5. The target vessel must be a native coronary artery with:

1. A stenosis ≥ 70% and < 100%, or

2. A stenosis ≥ 50% < 70% with evidence of clinical ischemia

6. The target vessel reference diameter must be ≥ 2.5mm and ≤ 4.0 mm.

7. The lesion length must not exceed 40 mm.

8. The target vessel must have a Thrombolysis In Myocardial Infarction (TIMI) flow three
(3) at baseline.

Exclusion Criteria:

1. Inability to understand the study or a history of non-compliance with medical advice.

2. Unwilling or unable to sign the MACE clinical study ICF.

3. History of any cognitive or mental health status that would interfere with study
participation.

4. Currently enrolled in any other pre-approval investigational study. This does not
apply to long-term post-market studies unless these studies might clinically
interfere with the current study endpoints (e.g., limit use of study-required
medication, etc.).

5. Female subjects who are pregnant or planning to become pregnant within the study
period.

6. Known hypersensitivity or contraindication to aspirin, heparin, ticlopidine or
clopidogrel without adequate alternative medications.

7. Known sensitivity to contrast media, which cannot be adequately pre-medicated.

8. Diagnosed with chronic renal failure unless under hemodialysis, or has a serum
creatinine level >2.5 mg/dl.

9. History of major cardiac intervention within 30-day, not including a PCI procedure
for a staging purpose.

10. Evidence of heart failure by one of the following:

i. Left Ventricular Ejection Fraction (LVEF) ≤ 25% ii. New York Heart Association
(NYHA) class III or IV iii. Clinical symptoms

11. History of a stroke or transient ischemic attack (TIA) within six (6) months

12. Active peptic ulcer or upper gastrointestinal (GI) bleeding within six (6) months.

13. History of bleeding diathesis or coagulopathy or intention to refuse blood
transfusion if one should become necessary.

14. Concurrent medical condition with a life expectancy of < 36 months.

15. History of immune deficiency.

16. Uncontrolled insulin dependent diabetes.

17. Evidence of active infections on the day of the index procedure.

18. Subject has planned cardiovascular intervention within 60 days post index procedure.

19. Subject with angiographically confirmed evidence of more than two (2) lesions within
one (1) vessel or more than one (1) vessel requiring intervention, unless the
treatment is staged. See Section 10.1 for more details.

20. Target lesion is located in a native vessel distal to anastomosis with a saphenous
vein graft or Left Internal Mammary Artery/ Right Internal Mammary Artery (LIMA/RIMA)
bypass.

21. Target vessel has angiographically visible or suspected thrombus.

22. Target vessel appears to be/is excessively tortuous at baseline.

23. Target lesion is an ostial location (within 5mm of ostium) or an unprotected left
main lesion.

24. Target lesion is a bifurcation (side branch ≥ 1.5mm).

25. Treatment of the target lesion with the CSI coronary Diamondback Orbital Atherectomy
System (OAS).
We found this trial at
34
sites
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials
330 Brookline Ave
Boston, Massachusetts 02215
617-667-7000
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
?
mi
from
Boston, MA
Click here to add this to my saved trials
800 Washington St
Boston, Massachusetts 02111
(617) 636-5000
Tufts Medical Center Tufts Medical Center is an internationally-respected academic medical center – a teaching...
?
mi
from
Boston, MA
Click here to add this to my saved trials
425 University Blvd.
Indianapolis, Indiana 46202
(317) 274-4591
Indiana University INDIANA UNIVERSITY is a major multi-campus public research institution, grounded in the liberal...
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
920 Madison Ave
Memphis, Tennessee 38163
?
mi
from
Memphis, TN
Click here to add this to my saved trials
Augusta, Georgia 30912
?
mi
from
Augusta, GA
Click here to add this to my saved trials
Baltimore, Maryland 21287
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bay City, Michigan 48708
?
mi
from
Bay City, MI
Click here to add this to my saved trials
5841 S Maryland Ave
Chicago, Illinois 60637
(773) 702-1000
University of Chicago Medical Center The University of Chicago Medicine has been at the forefront...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Clearwater, FL
Click here to add this to my saved trials
Columbia, Missouri 65201
?
mi
from
Columbia, MO
Click here to add this to my saved trials
Columbus, Ohio 43214
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Erie, Pennsylvania 16507
?
mi
from
Erie, PA
Click here to add this to my saved trials
Glendale, California 91206
?
mi
from
Glendale, CA
Click here to add this to my saved trials
1001 E 5th St
Greenville, North Carolina 27858
(252) 328-6131
East Carolina University Whether it's meeting the demand for more teachers and healthcare professionals or...
?
mi
from
Greenville, NC
Click here to add this to my saved trials
30 Prospect Ave
Hackensack, New Jersey 07601
(201) 996-2000
Hackensack University Medical Center Hackensack University Medical Center, part of the Hackensack University Health Network,...
?
mi
from
Hackensack, NJ
Click here to add this to my saved trials
80 Seymour St
Hartford, Connecticut 6102
(860) 545-5000
The Hartford Hospital Hartford Hospital is the major teaching hospital affiliated with the University of...
?
mi
from
Hartford, CT
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
Kansas City, Missouri 64111
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
Little Rock, Arkansas 72211
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
Miami Beach, Florida 33140
?
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Neptune, New Jersey 07754
?
mi
from
Neptune, NJ
Click here to add this to my saved trials
New Braunfels, Texas 78130
?
mi
from
New Braunfels, TX
Click here to add this to my saved trials
New York City, New York 10029
?
mi
from
New York City, NY
Click here to add this to my saved trials
Panama City, Florida 32401
?
mi
from
Panama City, FL
Click here to add this to my saved trials
320 E North Ave
Pittsburgh, Pennsylvania 15212
(412) 359-3131
Allegheny General Hospital At Allegheny General Hospital, our physicians and healthcare staff have earned an...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Raleigh, North Carolina 27607
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
Royal Oak, Michigan 48073
?
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Springfield, Illinois 62701
?
mi
from
Springfield, IL
Click here to add this to my saved trials
759 Chestnut Street
Springfield, Massachusetts 01199
(413) 794 - 0000
Baystate Medical Center Baystate Medical Center (BMC), in Springfield, Massachusetts, is an academic, research, and...
?
mi
from
Springfield, MA
Click here to add this to my saved trials
1 Barnes Jewish Hospital Plaza
St. Louis, Missouri 63110
(314) 747-3000
Barnes Jewish Hospital Barnes-Jewish Hospital at Washington University Medical Center is the largest hospital in...
?
mi
from
St. Louis, MO
Click here to add this to my saved trials
Tulsa, Oklahoma 74104
?
mi
from
Tulsa, OK
Click here to add this to my saved trials
Waco, Texas 76712
?
mi
from
Waco, TX
Click here to add this to my saved trials
Washington, District of Columbia 20010
?
mi
from
Washington,
Click here to add this to my saved trials